Issue 12, 2013

Novel benzofuran–chromone and –coumarin derivatives: synthesis and biological activity in K562 human leukemia cells

Abstract

Not widely distributed in nature, aurones, (Z)-2-benzylidene-benzofuran-3(2H)-ones, are one of the less common and lesser-known representatives of a flavonoid subclass. Nevertheless, they exhibit a strong and broad variety of biological activities. We have combined the benzofuranone part of a classical aurone with either a chromone or a coumarin scaffold which proved to feature interesting biological activities including antimicrobial, antiviral, anticancer, anti-inflammatory and antioxidant properties. Herein we present a series of 26 novel benzofuran derivatives with the first biological results in K562 human leukemia cells showing that compounds 21b, 29b and 29c are able to induce around 24% apoptosis.

Graphical abstract: Novel benzofuran–chromone and –coumarin derivatives: synthesis and biological activity in K562 human leukemia cells

Supplementary files

Article information

Article type
Concise Article
Submitted
26 Aug 2013
Accepted
18 Sep 2013
First published
18 Sep 2013

Med. Chem. Commun., 2013,4, 1571-1579

Novel benzofuran–chromone and –coumarin derivatives: synthesis and biological activity in K562 human leukemia cells

C. Zwergel, S. Valente, A. Salvato, Z. Xu, O. Talhi, A. Mai, A. Silva, L. Altucci and G. Kirsch, Med. Chem. Commun., 2013, 4, 1571 DOI: 10.1039/C3MD00241A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements